Addition of Icosapent Ethyl Cuts CV Risk in Patients With Prior PCI
Risk for cardiovascular events reduced when icosapent ethyl is added to statins in patients with elevated triglycerides and history of prior PCI
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.